Cardiovascular Monitoring and Diagnostic Devices Market Size and Growth Rate – (2019 - 2024)
The Market Value was worth USD 2245.9 million in 2019 and estimated to be growing at a CAGR of 7.18%, to reach USD 3176.7 million by 2024.
Cardiovascular Monitoring and Diagnostic Devices Market is published by the Market Data Forecast. Cardiovascular disease is a medical condition which affects the structure and function of organs associated with the function of the heart and its circulation
Cardio Vascular diseases are the primary cause of death and witnessing a high rise in prevalence. There are a large number of people being diagnosed with cardiovascular diseases such as periphery artery diseases, coronary artery diseases, congenital heart diseases, and pulmonary conditions shifting focus towards preventative healthcare.
Drivers
Increasing risks related to hypertension, heart muscle weakening, increasing the number of people suffering from diabetes and obesity are the major factors driving the market. Technological advancements have enabled additional features such as portability in performing various tests which are further adding to the growth of the Cardiovascular Monitoring market. However unclear reimbursement policies, strict government regulations for products and the high cost of monitoring devices are some the major factors hindering the growth of the market
Detailed Segmentation of the report:
Cardiovascular Monitoring and Diagnostic Devices Market -By Product:
ECG systems accounted for the largest share in the market and expected to maintain its stronghold in the market during the forecast period due to widespread availability and increasing preference for these devices in both developed and developing regions.
Cardiovascular Monitoring and Diagnostic Devices Market-By Region:
North America is the largest market for cardiovascular diagnostic and monitoring devices market and is expected to sustain its strong share owing to its favorable reimbursement policies and high awareness about available diagnosis and treatment methods among patients and physicians.
Asia-Pacific is estimated to be the fastest-growing region during the forecast period due to raising awareness about the effectiveness of accessible devices in successfully curing several cardiovascular conditions and increasing healthcare spending.
Companies leading the Global Cardiovascular Monitoring and Diagnostic Devices Market profiled in the report are
GE Healthcare and Phillips healthcare dominated the global Cardiovascular Monitoring and Diagnostic Devices Market accounting for an approximately 50% share.
Other major players covered in the report are
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 ECG Systems
5.1.1.1 Resting ECG Systems
5.1.1.2 Stress ECG Systems
5.1.2 Event Monitors
5.1.3 Holter Monitors
5.1.4 Implantable Loop Recorders
5.1.5 ECG Management Systems
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Philips Healthcare
8.3 Siemens Healthcare
8.4 Boston Scientific Corporation
8.5 St. Jude Medical, Inc
8.6 Nihon Kohden Corporation
8.7 Welch Allyn, Inc.
8.8 Spacelabs Healthcare
8.9 LivaNova PLC
8.10 Hill-Rom Holdings, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
